Gainers

  • Biofrontera BFRA stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $98.9 million.
  • Paratek Pharmaceuticals PRTK stock rose 9.76% to $4.27. The market value of their outstanding shares is at $214.3 million.
  • INmune Bio INMB shares increased by 9.38% to $12.0. The market value of their outstanding shares is at $214.1 million.
  • Revelation Biosciences REVB stock rose 7.17% to $2.39. The company's market cap stands at $34.0 million.
  • Black Diamond Therapeutic BDTX stock moved upwards by 6.95% to $4.0. The market value of their outstanding shares is at $144.9 million.
  • NeuroOne Medical Tech NMTC stock increased by 6.74% to $2.85. The market value of their outstanding shares is at $46.1 million. As per the news, the Q1 earnings report came out 4 days ago.

 

Losers

  • 10x Genomics TXG stock decreased by 23.1% to $73.0 during Friday's pre-market session. The company's market cap stands at $8.1 billion. As per the press release, Q4 earnings came out 2 days ago.
  • Marker Therapeutics MRKR stock fell 19.18% to $0.5. The company's market cap stands at $41.4 million. As per the press release, Q4 earnings came out 2 days ago.
  • Larimar Therapeutics LRMR shares fell 7.11% to $3.66. The market value of their outstanding shares is at $64.8 million.
  • Brickell Biotech BBI shares decreased by 6.53% to $0.24. The company's market cap stands at $27.1 million.
  • Dermata Therapeutics DRMA shares decreased by 6.35% to $1.18. The market value of their outstanding shares is at $9.8 million.
  • Orphazyme ORPH stock declined by 5.01% to $2.09. The market value of their outstanding shares is at $73.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!